Side-by-side comparison of AI visibility scores, market position, and capabilities
Columbus OH Midwest super-regional bank (NASDAQ: HBAN) ~$7.4B FY2024 revenue; 11-state footprint, auto dealer floorplan specialist, $200B+ assets, Fair Play Banking competing with Fifth Third and KeyCorp.
Huntington Bancshares Incorporated is a Columbus, Ohio-based regional bank holding company — publicly traded on the NASDAQ (NASDAQ: HBAN) as an S&P 500 Financials component — providing commercial and consumer banking, mortgage, auto finance, equipment finance, and wealth management services to customers across an 11-state Midwest footprint including Ohio, Michigan, Indiana, Pennsylvania, Kentucky, West Virginia, Colorado, Minnesota, Illinois, Wisconsin, and Wisconsin through approximately 19,000 employees. In fiscal year 2024, Huntington reported net revenues of approximately $7.4 billion and net income of approximately $1.7 billion, as the regional bank benefited from balance sheet repositioning — managing the interest rate sensitivity of its loan and deposit portfolios through the Federal Reserve's 2024 rate cutting cycle — while growing commercial loan originations in its expanded Midwest and Southeast US footprint. CEO Steve Steinour has led Huntington's decade-long expansion from a pure Ohio bank into a 11-state Midwest super-regional through the acquisitions of TCF Financial (Michigan, Minnesota — $6B acquisition in 2021) and Capstone Partners (investment banking boutique), creating a bank with $200+ billion in total assets that competes for middle market and small business banking in the auto industry supply chain, healthcare, government, and technology sectors concentrated in the Midwest. Huntington's "Fair Play Banking" brand positioning (pioneering 24-hour grace period on overdraft fees, Asterisk-Free Checking with no minimum balance, and small business lending commitment) differentiates Huntington from big national banks on consumer-friendly fee policies.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.